In Good Company with Nicolai Tangen cover image

GSK CEO: Drug Discovery, AI in Pharma, and Changing Company Culture

In Good Company with Nicolai Tangen

CHAPTER

Pandemic Preparedness and the Challenge of Antimicrobial Resistance

This chapter highlights the critical need for improved pandemic readiness and details initiatives by the pharmaceutical industry concerning vaccine contracts. It also addresses the threat of antimicrobial resistance and the ongoing research to develop new antibiotics to prevent future health crises.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner